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Cellular electrophysiological signatures of Parkinson’s disease described in the pharmacological 6-hydroxydopamine (6-OHDA) animal
models of Parkinson’s disease include spontaneous repetitive giant GABAergic currents in a subpopulation of striatal medium spiny
neurons (MSNs), and spontaneous rhythmic bursts of spikes generated by subthalamic nucleus (STN) neurons.We investigatedwhether
similar signatures are present in Pink1/ mice, a genetic rodent model of the PARK6 variant of Parkinson’s disease. Although 9- to
24-month-oldPink1/mice showreduced striatal dopamine content and release, and impaired spontaneous locomotion, the relevance
of this model to Parkinson’s disease has been questioned because mesencephalic dopaminergic neurons do not degenerate during the
mouse lifespan. We show that 75% of the MSNs of 5- to 7-month-old Pink1/mice exhibit giant GABAergic currents, occurring either
singly or in bursts (at 40Hz), rather than the low-frequency (2Hz), low-amplitude, tonic GABAergic drive common towild-typeMSNs of
the same age. STN neurons from 5- to 7-month-old Pink1/mice spontaneously generated bursts of spikes instead of the control tonic
drive. Chronic kainic acid lesion of the STN or chronic levodopa treatment reliably suppressed the giant GABAergic currents of MSNs
after 1month and replaced themwith the control tonic activity. The similarity between the in vitro resting states of Pink1MSNs and those
of fully dopamine (DA)-depleted MSNs of 6-OHDA-treated mice, together with the beneficial effect of levodopa treatment, strongly
suggest that dysfunctionofmesencephalic dopaminergic neurons inPink1/mice ismore severe than expected. Thebeneficial effect of
the STN lesion also suggests that pathological STN activity strongly influences striatal networks in Pink1/mice.
Introduction
Electrophysiological signatures of Parkinson’s disease (PD) de-
scribed in pharmacological animal models include spontaneous,
repetitive giant GABAergic currents occurring in50% of stria-
tal medium spiny neurons (MSNs), and spontaneous, rhythmic
bursts of spikes generated by glutamatergic neurons of the sub-
thalamic nucleus (STN) (Bergman et al., 1994; Benazzouz et al.,
2000; Dehorter et al., 2009). These signatures were recorded after
toxic lesion or dopamine depletion of the dopaminergic termi-
nals in the basal ganglia. Here we investigated whether similar
signatures are present in the genetic mouse model of the PARK6
variant of Parkinson’s disease in which midbrain dopaminergic
(mDA) neurons are preserved during the mouse lifespan.
Autosomal recessive PARK6-linked Parkinsonism, an early-
onset variant of Parkinson’s disease with slow progression, is caused
by loss-of-function mutations in the mitochondrial protein PINK1
(Bentivoglio et al., 2001; Gasser, 2009). PINK1 encodes the PTEN-
induced putative kinase 1 (PINK1), a ubiquitously expressed 581 aa
protein with a mitochondrial localization signal and a cytoplasmic
serine-threonine kinase domain (Zhou et al., 2008). In response to
cellular stress, PINK1 is transcriptionally induced with Parkin and
exerts a neuroprotective function (Mei et al., 2009; Klinkenberg et
al., 2012). 123I-FP-CIT-SPECTanalysis to determine the amount of
presynaptic dopamine transporter in PARK6 patients showed re-
duced binding, similar to idiopathic PD patients (Kessler et al.,
2005).
Pink1/mice have been generated to determine the mecha-
nisms underlying the PARK6 variant of PD. Pink1/mice show
reduced locomotor activity starting at 16 months (Gispert et al.,
2009). Horizontal activity, movement time, stereotypy count,
and center distance are decreased by 30% in open field, while
strength and coordination remain normal. Unlike the neurons of
Parkinson’s disease patients, mDA neurons of the Pink1/ do
not degenerate during the murine lifespan. However, striatal do-
pamine is significantly reduced by 9 months of age, evoked stri-
atal dopamine release is reduced and synaptic plasticity in
corticostriatal slices is disrupted by 3months (Kitada et al., 2007;
Gispert et al., 2009). These observations show that loss of mDA
neurons is not required for disruption of the Pink1/ motor
pathway, if dopamine release and its actions are altered. As such,
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this provides a unique model to determine the temporal corre-
spondence between electrophysiological signatures of Parkin-
son’s disease, motor pathology and degeneration of mDA
neurons.
Here, we used a variety of electrophysiological techniques in
slices in vitro to determine whether Pink1/ mice have the ex-
pected electrophysiological signatures of dopamine depletion
(Bergman et al., 1994; Benazzouz et al., 2000; Dehorter et al.,
2009). We report that in slices from Pink1-deficient brains 10
months before the onset of motor deficits, the striatum exhibits
the characteristic signs of DA depletion; spontaneous, repetitive,
giant GABAergic currents in MSNs and spontaneous, rhythmic
bursts of spikes in neurons of the STN. In addition, either unilat-
eral kainic acid lesion of the STN or chronic levodopa treatment
can rescue the Pink1/ striatal pathology.
Materials andMethods
Slice preparation. Mice from the 129sv strain of either sex, either wild-
type (wt) or Pink1/mutant, were killed at age 5–7 months by decap-
itation under halothane anesthesia. Oblique parasagittal slices (380 m
thick) were cut with an angle of 10 2° to obtain the basal ganglia slice
(BGS) as described previously (Beurrier et al., 2006). For the slicing
procedure, the ice-cold oxygenated solution contained (inmM) 110 cho-
line, 2.5 KCl, 1.25 NaH2PO4, 7MgCl2, 0.5 CaCl2, 25 NaHCO3, 7 glucose.
During the recovery period, BGSs were placed at room temperature with
standard artificial CSF (ACSF) saturated with 95%O2/5%CO2 and con-
taining (inmM): 126NaCl, 3.5 KCl, 1.2NaH2PO4, 1.3MgCl2, 2 CaCl2, 25
NaHCO3, 11 glucose.
STN lesion. We unilaterally lesioned the STN in Pink1/ mice aged
5–7 months by local stereotaxic injection of kainic acid under 5% ket-
amine (Imalge`ne 1000)–2.5% xylazine (Rompun 2%) anesthesia (8–10
l/g, i.p.). The microinjection of kainic acid was performed through a
NanoFIL syringe (outside diameter 135 m, WPI) placed into the left
STN at the following coordinates using a David Kopf stereotaxic appara-
tus: 0.7 mm rostral to bregma, 1.48 mm lateral to the midline, 4.55 mm
below the surface of the skull. Kainic acid was dissolved in saline and
injected at a dose of 1 mg/ml in a volume of 0.3 l over a 3 min period.
The syringe was left in place for 3 min after the end of injection. We
performed in vitro recordings at least 30 d after the lesion. The efficacy of
the STN lesion was determined just after recovery from anesthesia on
video film (lying on the left side with the right hindlimb in extension),
documented in films of lesion effects (see Notes). We checked the extent
of the lesion by counting the number of double-labeled neurons with
NeuN (neuronal-specific nuclear protein) and DAPI (4,6-diamidino-
2-phenylindole dihydrochloride) in serial 100 m sections of the STN
(see Immunocytochemistry).
Levodopa treatment.We treated Pink1/mice aged 5–7months over
a 15 d period with a daily injection of benserazide hydrochloride (DL-
serine 2-(2,3,4-trihydroxybenzyl)hydrazide hydrochloride, 10 mg/kg,
i.p.), a DOPA decarboxylase inhibitor that does not cross the blood–
brain barrier, and 20 min later a levodopa injection (10 mg/kg, i.p.).
Electrophysiology. All recordings were made at 32°C. Cells were visual-
izedwith infrared-differential interference optics (Axioskop2, Zeiss). For
whole-cell voltage-clamp recordings of postsynaptic GABAA currents,
the pipette (6–10 M) contained (in mM): 120 Cs-gluconate, 13 CsCl, 1
CaCl2, 10 HEPES, 10 EGTA, pH 7.2–7.4, 275–285 mOsm, or (in mM):
128.5 K-gluconate, 11.5 KCl, 1 CaCl2, 10 EGTA, 10 HEPES, 2.5 MgATP,
and 0.3 NaGTP, pH 7.32, 280 mOsm. The CsGlu and KGlu pipette solu-
tions gave a reversal potential for chloride close to58 and63 mV at
35°C, respectively. Biocytin (Sigma, 5 mg/ml) was added to the pipette
solution and osmolarity was corrected when necessary. We performed
patch-clamp recordings in whole-cell configuration using the Digidata
1344A interface, the Multiclamp 700A amplifier, and PClamp8 software
(Molecular Devices). We identified MSNs during recordings based on
their typical rectification during hyperpolarizing steps and their firing
delay in response to depolarizing steps. STN neurons were identified
during recordings by their position inside the STN. MSNs and STN
neurons were also identified by their morphological characteristics after
the recording session (see Immunocytochemistry).
We measured spontaneous GABAA currents (GABAA sPSCs) from
MSNs in voltage-clamp mode at the reversal potential for glutamatergic
(10 mV) events (Cossart et al., 2000). These currents were stored on
Pclamp8 (Molecular Devices) and analyzed off-line with Mini Analysis
program (Synaptosoft 6.0), Clampfit 9.2, Origin 5.0, and Autosignal 1.7
to determine the frequency and amplitude of GABAA sPSCs. All detected
currents were then visually inspected to reject artifactual events. As pre-
viously published (Dehorter et al., 2009), we defined as “giant” any single
GABAA sPSC with an amplitude 200 pA, because such sPSCs were
rarely recorded in wt MSNs (on average only nine events per cell; see
Results). We defined as a burst a minimum of five sPSCs associated with
a baseline elevation. More than five giant events and three bursts were
required during the 3 min analysis for the pattern to be deemed “oscilla-
tory.” The current charge was automatically calculated by theMini Anal-
ysis Software as the area under the curve value (taking the onset, peak and
decay time points as references for each event).We recorded STNneuron
activity in current or voltage-clamp modes, with patch electrodes filled
with the K-gluconate solution.
Drugs.Drugswerepreparedasconcentratedstocksolutionsanddiluted in
ACSF for bath application: bicuculline, a GABAA receptor antagonist,
D-()-2-amino-5-phosphonopentanoic acid (D-APV), a NMDA receptor
antagonist, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), an AMPA-
kainate receptor antagonist, and kainic acid. All drugs were purchased
from Sigma. DL-Serine 2-(2,3,4-trihydroxybenzyl)hydrazide hydro-
chloride (benserazide) and -methyl-L-tyrosine (levodopa) were
purchased from Sigma.
Immunocytochemistry. After the recording session, to visualize and iden-
tify the recorded neurons in the striatum and the STN, we visualized the
biocytin injected during whole-cell recordings. After 24 h in paraformalde-
hyde (3%)at 4°C, the sectionswere rinsed inPBSandpreincubated for1h in
0.3% Triton X-100 (Abcys) in PBS with 5% normal goat serum (NGS) at
room temperature. Slices were then incubated in Streptavidin-Cy3 (1:500)
in PBS-Triton X-100 (0.3%) and NGS (5%) during 12 h at 4°C. After thor-
ough rinsing, slices were mounted in Fluoromount and coverslipped. Con-
focal Imageswere takenwith a Leica SP5-X and stackswere filtered (median
3D) and stitched (3D stitching) with FIJI software (ImageJA v1.46b, Open
source software, http://pacific.mpi-cbg.de). Dendritic and axonal arbors
were reconstructed formorphological analysisusing theNeurolucida system
(MicroBrightField Inc.). All themeasures of dendritic lengthwere corrected
in each plane individually with a shrinkage factor to compensate for dehy-
drationandprocessingof slices (Pyapali et al., 1998). For visualizing theSTN
lesion we performed NeuN (Neuronal Nuclei) immunocytochemistry
(mouse monoclonal antibody, 1:1000, Millipore Bioscience Research Re-
agents) detected by Cy3 streptavidin (1:1000). Then slices were counter-
stained with DAPI.
Statistics. For statistical comparison of data we performed nonpara-
metric Mann–Whitney tests unless otherwise stated.
Results
Spontaneous GABAA currents increase in amplitude and shift
to oscillatory mode in Pink1/MSNs
Seventy percent of the recorded MSNs (n  7/10) from 5- to
7-month-old wt mice displayed a tonic pattern of GABAA sPSCs,
with low-frequency (1.7  0.8 Hz) and low-amplitude events
(32.6 2.9 pA) (Fig. 1A1). The current charge of this tonic pat-
tern averaged 134 56 nA.ms. In the other 30% of the recorded
MSNs (n 3/10) we also recorded rare giant (200 pA) currents
(mean amplitude: 219  5 pA; range: 201–246 pA, mean fre-
quency: 0.032 0.004 Hz; n 27 events/3 cells) (Fig. 1A2). The
overall current charge of this pattern was 343 218 nA.ms. Be-
cause there was no significant difference between the total cur-
rent charge of the two patterns (p 0.4), these data were pooled
(A1A2, mean current charge 197 75 nA.ms, Fig. 1C).
In 5- to 7-month-old Pink1/MSNs (n 27) a new pattern
emerged, characterized by a much higher total current charge
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(1096  289 nA.ms, p  7.104 com-
pared with (A1A2) due to the presence
of numerous giant GABAA sPSCs occur-
ring either singly or in bursts. Single giant
GABAA sPSCs had a higher amplitude
(340  25 pA; range: 200–1100 pA, n 
532 events/17 cells; p  1 	 104) and a
higher frequency (0.23  0.06 Hz; p 
0.03) than giant sPSCs from control mice
(Fig. 1B1,C). When present, bursts of
GABAA sPSCs recurred at intervals of
45.5  17.1 s during periods of 461.7 
50.4 ms (Fig. 1B2) with a mean intraburst
frequency of 38.5  3.8 Hz and a mean
amplitude of 82.5  7.6 pA (n  112
events/10 cells). This new giant and oscil-
latory pattern was observed in 74% of the
recorded Pink1/MSNs (n 20/27). In
the remaining 26% of Pink1/ MSNs
(n 7/27), GABAA sPSCswere tonic (Fig.
1B3) with a mean current charge (232 
65 nA.ms) andmean frequency (2.1 0.5
Hz) similar to those of the control tonic
pattern but with a higher mean amplitude
(48.9 4.8 pA) (p 0.3, p 0.7, p 0.01
respectively; nonpaired Student’s t test;
n 7) (Fig. 1C). In conclusion, spontane-
ous GABAA sPSCs from Pink1
/ mice
were strikingly large and bursty in70%
of MSNs assayed.
STN lesion or chronic levodopa
treatment returns the giant or
oscillatory pattern of GABAA currents
of Pink1/MSNs to control
STN neurons of Pink1/mice displayed
the characteristic electrophysiological sig-
nature of dopamine-depletion; i.e., recur-
rent, spontaneous bursts of spikes as
reported in rodent and primate pharma-
cological models of PD (Hammond et al.,
2007). This is in contrast to STN neurons
from 5- to 7-month-old wt mice which
displayed regular tonic activity (Fig.
2A,B). STN bursts of spikes in themutant
mice were generated by spontaneous
bursts of EPSPs as shown by patch-clamp
recordings in current-clamp mode in the
continuous presence of the GABAA recep-
Figure 1. Spontaneous GABAA currents recorded from MSNs in basal ganglia slices from 5- to 7-month-old wt or Pink1
/
mice. Voltage-clamp recordings of GABAA sPSCs (VH10 mV) at two different time scales. A, Tonic pattern of GABAA sPSCs in
wt striatum in theabsence (70%ofMSNs;A1) or rarepresenceof single sPSCs200pA (F) (30%ofMSNs;A2).B1,B2, Oscillatory
pattern of GABAA sPSCs recorded in Pink1
/ striatum observed in 74% of MSNs and characterized by the frequent presence of
giant events: single sPSCs (F) and bursts of sPSCs (f) (B1, B2). B3, Tonic pattern in the remaining MSNs (26%). The calibration
of event amplitude is the same for all recordings in A and B and the scale is identical for the left and right column. C (from left to
4
right), Quantification of the data from wt MSNs as shown in
A1A2 (white) and from Pink1/ MSNs as shown in
B1B2 (black) or B3 (gray). The mean current charge of
GABAA sPSCs increased fivefold betweenA1A2 andB1B2.
Giant events represented 9% and 38% of the total current
charge in A2 and B1B2, respectively, and the baseline
events (
200 pA) represented 91% and 62% of the total cur-
rent charge inA1A2 and B1B2, respectively. The distribu-
tion of single giant sPSCs 200 pA shows the increased
number of these events and the presence of very large ampli-
tude events (1000 pA) in B1B2 compared with A2. Error
bars indicate SEM. **p
 0.01.
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tor antagonist, gabazine (5 M). Recorded in voltage-clamp
mode (VH  60 mV) in the presence of gabazine (5 M), the
corresponding spontaneous EPSCs also displayed a bursting pat-
tern. They were completely blocked by the application of antag-
onists of ionotropic glutamatergic receptors CNQX (10 M)
and D-APV (40 M; data not shown) (Ammari et al., 2011).
We next tested whether kainate lesion of the dysfunctional
STN would rescue the electrophysiological signature of dopa-
mine depletion in the striatum of Pink1/ mice. In 5- to
7-month-old Pink1/mice where at least 80% of STN neurons
were lost after kainic acid injection (Fig. 2A right, C), without
alteration of mDA neurons or their terminals in the striatum
(data not shown), the first observationwas a significant change in
morphological characteristics of MSNs. Though Neurolucida re-
constructed biocytin-labeled MSNs from Pink1/ mice before
and after STN lesion had a similar mean number of dendritic
trunks (6.0  0.3 vs 5.0  0.5, p  0.09), the dendritic tree of
Pink1/MSNs occupied a much larger volume when the STN
was intact ((16.2  8.6) 	 106 m3, n  22) than when it was
lesioned ((2.5  0.3) 	 106 m3, n  14, p  0.003) (Fig. 3A,
top). Accordingly, the mean dendritic length of the Pink1/
MSNs (2970 255m, n 20) was significantly longer than the
mean dendritic length of MSNs from Pink1/ STN-lesioned
mice (2085 72m, n 14; p 0.003). This effect wasmaximal
at distances of 130 and 170 m from the soma upon comparison
of Pink1/ animalswith STN intact (942 64mand542 77
m) versus lesioned (600 52 and 148 38 m, p 0.001 and
0.0001 respectively). The mean number of intersections at 130
and 170 m from the soma was significantly higher in Pink1/
MSNs when the STN was intact (16.2 2.4 and 10.7 3.6) than
when it was lesioned (5.7 1.2 and 0.7 0.4) (p 0.0001 and
0.0002, respectively; Fig. 3A, bottom).
In 79% of MSNs from STN-lesioned Pink1/ mice we ob-
served tonic GABAA sPSCs (n 30/38) with characteristics sim-
ilar to those recorded from wt MSNs of the same age (p 0.13);
i.e., with low-frequency (3.0  0.5 Hz) and low-amplitude
(41.7 2.2 pA) events and without giant or bursting events (Fig.
3B1). The mean total current charge (287 65 nA.ms, 94 2%
of the total current charge) was also similar (p  0.1) to that of
tonic sPSCs from Pink1/ MSNs (Fig. 3B3, left). Either single
giant GABAA sPSCs (n  7/38 MSNs; Fig. 3B2) or rare bursts
(n  1/38 MSN) were observed in the remaining 21% of MSNs
(n  8/38 cells). These giant GABAA sPSCs had a lower mean
amplitude (240.7 3.7 pA; range, 203–341 pA; n 84 events/7
cells, p 0.002; Fig. 3B3) but a similar frequency (0.20 0.11Hz;
p 0.9) to Pink1/MSNs.
To test whether decreased phasic release of dopamine in the
basal ganglia circuit underlies both above observations, we
chronically treated Pink1/mice with levodopa (see methods)
and recorded spontaneous GABAA sPSCs from MSNs. All re-
cordedMSNs (100%, n 9) displayed a tonic pattern of GABAA
sPSCs similar to those recorded from wt MSNs of the same age
i.e., without giant or bursting events (Fig. 3C1,C2). GABAA sPSCs
had a frequency (0.9  0.4 Hz), amplitude (47.6  7.9 pA) and
mean current charge (59 19 nA.ms) that were not significantly
different from those of the tonic pattern recorded inwt (p 0.25,
p  0.47 and p  0.11, respectively) or in Pink1/ (p  0.04,
p 0.8 and p 0.02, respectively) MSNs (Fig. 3C3).
Discussion
Our results show that Pink1/mouse basal ganglia are charac-
terized by specific electrophysiological signatures. PINK1 defi-
ciency profoundly alters transmission through GABAA receptors
in 75%of striatalMSNs, causing oscillatory currents consisting of
giant sPSCs and/or bursts of sPSCs. It also shifts STN neuronal
activity from single spikes to rhythmic bursts. Similar signatures
were previously identified in vitro in severe dopaminergic defi-
ciency states produced pharmacologically (Hammond et al.,
2007; Dehorter et al., 2009; Ammari et al., 2011).
Figure 2. Characteristics of the STN and STN neurons from wt, Pink1/ and Pink1/ STN-lesioned mice. Example traces of the spontaneous bursting activity of Pink1/ STN neurons
(current clamp,whole cell, Vm70mV,A, left) comparedwith the spontaneous tonic activity ofwt STN neurons (Vm70mV,B, left) and corresponding inter spike interval histograms (bin:
10ms) (A,B, middle). Confocal images of the NeuN-positive neurons in Pink1/ STN from the nonlesioned (A, right) and lesioned (C) sides (stacks of 16m thickness). The lesion was restricted
to the STN region (STN part of zona incerta) and did not extend to the thalamus.
18050 • J. Neurosci., December 12, 2012 • 32(50):18047–18053 Dehorter et al. • Giant GABAergic Currents in PINK1 KO Striatum
Figure 3. Spontaneous GABAA currents recorded from MSNs in basal ganglia slices from 5- to 7-month-old Pink1
/ mice bearing a chronic lesion of the STN or chronically treated with
levodopa.A, Top, Neurolucida reconstruction of biocytin-filled Pink1/MSNs in theabsence (left) or presence (right) of anSTN lesion. Thehistogram in themiddle indicates the (Figure legend continues.)
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Our previous work using 6-hydroxydopamine (6-OHDA)-
treated mice as a model of dopamine depletion in late-stage PD
showed the occurrence of giant GABAA sPSCs in MSNs, not as-
sociated with changes in the reversal potential for GABA or the
resting membrane potential, or alteration of cholinergic signals.
Rather, these giant sPSCs result from a change in the activity of
GABAergic low-threshold spike (LTS) interneurons of the stria-
tum. This leads to the generation of repetitive giant bursts of
GABAcurrents in a large subpopulation ofMSNs. In the STN, the
dopamine-depleted state also results in a burst of spikes, but the
mechanism is still a matter of controversy. We and others have
suggested that dopamine depletion uncovers a polysynaptic glu-
tamatergic network within the STN that generates bursts of
EPSCs and spikes specifically when activated by cortical afferents
(Shen and Johnson, 2006; Ammari et al., 2010, 2011). The role of
the subthalamopallidal-pallidosubthalamic loop, which was first
suggested as central (Plenz and Kital, 1999), now seems accessory
(Tachibana et al., 2011).
Increased bursting activity of striatal LTS interneurons was
previously observed after nearly complete dopamine depletion or
mild loss of dopaminergic neurons (Janssen et al., 2012). How-
ever, the observation of similar electrophysiological signatures in
5- to 7-month-old Pink1/ mice came as a surprise, as mDA
neurons in these animals are intact, their striatal dopamine levels
are only moderately reduced (20%), and they display no signifi-
cant locomotor deficit at this age (Gispert et al., 2009). Our data
are supported by an independent report that Pink1/mice have
hyperexcitable mDA neurons with enhanced burst firing and a
functional reduction in the activity of small-conductance Ca2-
activated potassium channels (Bishop et al., 2010). This early
hyperexcitability may suggest that impaired dopamine signaling
in the striatum and, in particular the STN (Kitada et al., 2007) is
the limiting factor even more than dopamine deficiency.
It is interesting that this striatal hyperexcitability can be res-
cued by homolateral STN lesion (Centonze et al., 2005). The STN
area is a well known target for surgical therapy in PD patients,
either through lesion approaches or deep brain stimulation (Lim-
ousin et al., 1995; Okun and Vitek, 2004; Bronstein et al., 2011).
Our observations suggest that the Pink1/mice are a model for
not only the electrophysiological anomalies typical of early-stage
PD, they are also a useful tool to study the surgical modulation of
impaired neural circuit function in PD. The mechanism under-
lying the reversal of MSN GABAA activity by chronic lesion of
STN neurons is not studied here, but is likely to result from the
suppression of STN bursting neurons and transmission of the
bursting pattern to corticostriatal networks either directly via
the subthalamo-cortical (Degos et al., 2008) and subthalamo-
striatal (Kita and Kitai, 1987) pathways or indirectly via thalamic
neurons (Smith et al., 1998).
In view of the age-association of PD, it will be important to
investigate at what age these electrophysiological alterations ap-
pear in genetic mouse models, whether they progress over time
and how they are modulated by current PD medications. In
A53T--synuclein overexpressing mice as a model of autosomal
dominant PD variants, early deficits of striatal dopaminergic sig-
naling were shown to progress with age and to result in patholog-
ical synaptic plasticity, which was reversible after administration
of the phosphodiesterase inhibitor zaprinast (Kurz et al., 2010;
Platt et al., 2012; Tozzi et al., 2012).
In conclusion, we observed oscillatory patterns of activity in
Pink1/ projection neurons of the dorsal striatum and the STN,
which are similar to those observed in dopamine-depletedMSNs
and STN neurons in pharmacological rodent models of PD. This
suggests that the dopaminergic dysfunction in these two major
targets of mDA neurons is more severe, at least at rest, than ex-
pected from amperometric measures in response to local striatal
stimulation (Kitada et al., 2007). The presence of these electro-
physiological signatures10months before the onset of locomo-
tor deficits (Gispert et al., 2009) also provides an interesting early
read-out (Ben-Ari, 2008) to assess the severity of pathology in
genetic mouse models of PD. Finally, the successful reversal of
this pathological hyperexcitability by STN lesions establishes a
path by which to investigate the benefit of PD therapies and their
mechanism. The Pink1/ mouse model of PD is thus a useful
tool to study early stages of the disease process, where reversible
neuronal dysfunction rather than irreversible neuron loss domi-
nate in the brain.
Notes
Supplemental material for this article is available at http://www.inmed.
univ-mrs.fr/index.php?page15&id15. Photos of Pink1 KOmice just af-
ter the hemilateral lesion of the subthalamic nucleus. This material has not
been peer reviewed.
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